EpCAM overexpression is correlated with poor disease free suvival in breast cancer[18], and loss of EpCAM expression in gastric adenocarcinoma has been reported to be associated with poor TNM staging prognosis[10], although inconsistent[19]. Here, EPCAM is linked to breast cancer.